A team of researchers from Université de Saint-Boniface (USB) in Manitoba has proven the effectiveness of a disinfectant that could revolutionize the fight against superbugs in the hospital system. Mathias Oulé, Ph.D., microbiology professor at Manitoba’s Université de Saint-Boniface, conducted a study revealing that Akwaton tackles spore-forming bacteria, including Clostridium difficile whose heat-tolerant spores can live on surfaces for long periods of time and survive a number of years in a dry environment.
Most currently available chemical disinfectants only control or prevent the spread of bacterial spores whereas this study revealed that Akwaton is able to destroy Bacillus subtilis spores at very dilute concentrations, after just 90 seconds’ treatment. According to Dr. Oulé, “Most disinfectants have to be applied at much higher concentrations – typically between 4 and 10% – which may be harmful to humans. Akwaton destroys spores at concentrations well below 1%.” Akwaton is non-corrosive, non-irritating, non-toxic, odourless and environmentally safe.” The USB research team has also shown that Akwaton is effective against strains of Methicillin-resistant Staphylococcus aureus and Escherichia coli.
